RxDoctor Payments Data

Charu Patel, MD

Psychiatry · Taunton, MANPI 1780644294

Payments from drug & device makers

$3,944in general payments, 2019–2025

Across 226 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$436
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$370
  • Sunovion Pharmaceuticals Inc.$309
  • Neurocrine Biosciences, Inc.$271
  • Otsuka America Pharmaceutical, Inc.$244
  • plus $460 from 7 others

What the payments were for

  • Food & beverage$3,59991%
  • Education$3459%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,944 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$78,967
Medicare patients
119
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine23$224,941
Invega SustennaPaliperidone Palmitate23$60,923
VraylarCariprazine Hcl37$53,554
TrintellixVortioxetine Hydrobromide26$13,696
Clozapine274$12,865
InvegaPaliperidone12$8,771
AbilifyAripiprazole16$7,856
Clozapine OdtClozapine22$6,060
Divalproex Sodium191$5,536
Fluoxetine Hcl291$4,833
Olanzapine201$4,108
Buspirone Hcl271$3,265
Oxcarbazepine61$2,996
Quetiapine Fumarate178$2,825
Benztropine Mesylate196$2,807

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$436$224,94123 claims
Johnson & JohnsonInvega Sustenna, Invega$132$69,69435 claims
AbbVieVraylar$1,854$53,55437 claims
E.r. Squibb & Sons, L.L.C.Abilify$44$7,85616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Taunton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →